[AXIATA] YoY Quarter Result on 31-Dec-2017 [#4]

Stock
[AXIATA] AXIATA GROUP BERHAD
Announcement Date
22-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- -89.63%
YoY- 107.99%
Quarter Report
Latest QR
Upcoming QR
AXIATA's Result
AXIATA's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 6,262,516 6,267,007 6,266,995 6,261,095 5,789,422 5,360,437 4,813,422 4.47%
PBT -533,859 632,278 -1,710,794 410,578 -273,642 829,688 849,093 -
Tax 135,452 -228,135 -309,939 -308,277 1,580 -314,449 -228,891 -
NP -398,407 404,143 -2,020,733 102,301 -272,062 515,239 620,202 -
-
NP to SH -255,959 332,558 -1,661,923 24,725 -309,496 467,235 599,242 -
-
Tax Rate - 36.08% - 75.08% - 37.90% 26.96% -
Total Cost 6,660,923 5,862,864 8,287,728 6,158,794 6,061,484 4,845,198 4,193,220 8.01%
-
Net Worth 17,605,481 16,189,980 17,542,688 24,641,894 23,256,414 23,538,064 20,865,731 -2.78%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 458,476 411,609 409,026 315,921 265,282 1,057,890 1,207,108 -14.88%
Div Payout % 0.00% 123.77% 0.00% 1,277.74% 0.00% 226.42% 201.44% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 17,605,481 16,189,980 17,542,688 24,641,894 23,256,414 23,538,064 20,865,731 -2.78%
NOSH 9,169,541 9,163,573 9,071,017 9,047,951 8,842,742 8,815,754 8,622,202 1.03%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -6.36% 6.45% -32.24% 1.63% -4.70% 9.61% 12.88% -
ROE -1.45% 2.05% -9.47% 0.10% -1.33% 1.99% 2.87% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 68.30 68.52 68.95 69.36 65.47 60.81 55.83 3.41%
EPS -2.80 3.60 -18.30 0.30 -3.50 5.30 7.00 -
DPS 5.00 4.50 4.50 3.50 3.00 12.00 14.00 -15.75%
NAPS 1.92 1.77 1.93 2.73 2.63 2.67 2.42 -3.78%
Adjusted Per Share Value based on latest NOSH - 9,047,951
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 68.20 68.25 68.25 68.18 63.05 58.37 52.42 4.47%
EPS -2.79 3.62 -18.10 0.27 -3.37 5.09 6.53 -
DPS 4.99 4.48 4.45 3.44 2.89 11.52 13.15 -14.90%
NAPS 1.9172 1.7631 1.9104 2.6835 2.5326 2.5633 2.2723 -2.78%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 3.74 4.14 3.93 5.49 4.72 6.41 7.05 -
P/RPS 5.48 6.04 5.70 7.91 7.21 10.54 12.63 -12.98%
P/EPS -133.98 113.87 -21.49 2,004.23 -134.86 120.94 101.44 -
EY -0.75 0.88 -4.65 0.05 -0.74 0.83 0.99 -
DY 1.34 1.09 1.15 0.64 0.64 1.87 1.99 -6.37%
P/NAPS 1.95 2.34 2.04 2.01 1.79 2.40 2.91 -6.44%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 25/02/21 21/02/20 22/02/19 22/02/18 23/02/17 17/02/16 25/02/15 -
Price 3.57 4.25 4.25 5.67 4.71 5.90 7.17 -
P/RPS 5.23 6.20 6.16 8.17 7.19 9.70 12.84 -13.89%
P/EPS -127.89 116.89 -23.24 2,069.94 -134.57 111.32 103.17 -
EY -0.78 0.86 -4.30 0.05 -0.74 0.90 0.97 -
DY 1.40 1.06 1.06 0.62 0.64 2.03 1.95 -5.36%
P/NAPS 1.86 2.40 2.20 2.08 1.79 2.21 2.96 -7.44%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment